Приказ основних података о документу
TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions
dc.creator | Santibanez, Juan F. | |
dc.creator | Quintanilla, Miguel | |
dc.creator | Bernabeu, Carmelo | |
dc.date.accessioned | 2021-04-20T12:23:44Z | |
dc.date.available | 2021-04-20T12:23:44Z | |
dc.date.issued | 2011 | |
dc.identifier.issn | 0143-5221 | |
dc.identifier.uri | http://rimi.imi.bg.ac.rs/handle/123456789/333 | |
dc.description.abstract | The TGF-beta (transforming growth factor-beta) system signals via protein kinase receptors and Smad mediators to regulate a plethora of biological processes, including morphogenesis, embryonic development, adult stem cell differentiation, immune regulation, wound healing and inflammation. In addition, alterations of specific components of the TGF-beta signalling pathway may contribute to a broad range of pathologies such as cancer, cardiovascular pathology, fibrosis and congenital diseases. The knowledge about the mechanisms involved in TGF-beta signal transduction has allowed a better understanding of the disease pathogenicity as well as the identification of several molecular targets with great potential in therapeutic interventions. | en |
dc.publisher | Portland Press Ltd, London | |
dc.relation | Spanish Ministry of Science and Innovation Spanish Government [SAF2010-19222, SAF2010-19152] | |
dc.relation | Genoma Espana [MEICA] | |
dc.relation | Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Raras | |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175062/RS// | |
dc.rights | restrictedAccess | |
dc.source | Clinical Science | |
dc.subject | cancer | en |
dc.subject | cardiovascular disease | en |
dc.subject | fibrosis | en |
dc.subject | reproductive disorder | en |
dc.subject | Smad protein | en |
dc.subject | transforming growth factor-beta (TGF-beta) | en |
dc.subject | transforming growth factor-beta receptor | en |
dc.title | TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions | en |
dc.type | article | |
dc.rights.license | ARR | |
dc.citation.epage | 251 | |
dc.citation.issue | 5-6 | |
dc.citation.other | 121(5-6): 233-251 | |
dc.citation.rank | M21 | |
dc.citation.spage | 233 | |
dc.citation.volume | 121 | |
dc.identifier.doi | 10.1042/CS20110086 | |
dc.identifier.pmid | 21615335 | |
dc.identifier.scopus | 2-s2.0-79961139550 | |
dc.identifier.wos | 000295106200005 | |
dc.type.version | publishedVersion |